Redmile Group’s Hinge Health HNGE Stock Holding History

Redmile Group’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300,000	Closed	-$15.5M	–	48
2025 Q2	$15.5M	Buy	+300,000	New	+$12.1M	1.65%	16

Other funds holding HNGE

IHG

Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Redmile Group's HNGE Position: Q3 2025 in Review

Redmile Group sold out of Hinge Health (HNGE) in Q3 2025, closing a stake of 300,000 shares — an estimated $15.5M sold.

Redmile Group first reported a position in HNGE in Q2 2025 and held it in 1 quarter. The position peaked at $15.5M in Q2 2025. 146 funds tracked by Wall St. Rank hold HNGE as of Q3 2025.

Redmile Group reported no remaining Hinge Health position as of Q3 2025 after selling out during the quarter.
Redmile Group sold 300,000 Hinge Health shares in Q3 2025, an estimated $15.5M.
Redmile Group first reported a position in Hinge Health in Q2 2025 and held it in 1 quarter.
Redmile Group's Hinge Health position peaked at $15.5M in Q2 2025.
146 funds tracked by Wall St. Rank held Hinge Health as of Q3 2025.

Based on Redmile Group's 13F filing for Q3 2025, filed 14 Nov 2025.